| __timestamp | Ionis Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 6795238 |
| Thursday, January 1, 2015 | 37173000 | 7454247 |
| Friday, January 1, 2016 | 48616000 | 10345862 |
| Sunday, January 1, 2017 | 108488000 | 16984203 |
| Monday, January 1, 2018 | 244622000 | 16187290 |
| Tuesday, January 1, 2019 | 287000000 | 9299233.54 |
| Wednesday, January 1, 2020 | 354000000 | 19232000 |
| Friday, January 1, 2021 | 186000000 | 23611000 |
| Saturday, January 1, 2022 | 151000000 | 26700000 |
| Sunday, January 1, 2023 | 232600000 | 28215000 |
| Monday, January 1, 2024 | 267474000 |
Cracking the code
In the competitive world of biotechnology, managing operational costs is crucial. This chart compares the Selling, General, and Administrative (SG&A) expenses of Summit Therapeutics Inc. and Ionis Pharmaceuticals, Inc. from 2014 to 2023. Ionis Pharmaceuticals, a leader in RNA-targeted therapeutics, has seen its SG&A expenses grow significantly, peaking in 2020 with a 1,660% increase from 2014. Meanwhile, Summit Therapeutics, known for its innovative antibiotic solutions, has maintained a more modest growth, with expenses increasing by approximately 315% over the same period. This disparity highlights Ionis's aggressive expansion and investment in its operations compared to Summit's more conservative approach. As the biotech industry continues to evolve, understanding these financial strategies provides valuable insights into each company's market positioning and future potential.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights